Social networks
2,994Activities
Entity types
Location
Box 289, Addenbrooke’s Hospital, Cambridge CB2 0QQ, UK
Cambridge
United Kingdom
Employees
Scale: 51-200
Estimated: 73
Engaged corporates
4Added in Motherbase
3 years, 1 month agoA University of Cambridge department pursuing research to improve the health of people in the UK and around the world.
Obesity, type 2 diabetes and related metabolic disorders present a major and growing global public health challenge. These disorders result from a complex interplay between genetic, developmental, behavioural and environmental factors that operate throughout life.
The mission of the MRC Epidemiology Unit is to investigate the individual and combined effects of these factors and to develop and evaluate strategies to prevent these diseases and their consequences.
In this way, we are working to improve the health of people in the UK and around the world.
We are a Medical Research Council Unit embedded as a department of the University of Cambridge School of Clinical Medicine.
The Unit is part of the Wellcome – MRC Institute of Metabolic Science (IMS) on the Cambridge Biomedical Campus, where the principle offices and laboratories of the Unit are physically located. Unit Director Professor Nick Wareham is Co-Director of the IMS with Professor Sir Stephen O’Rahilly. Being embedded in the IMS is critical to our aspiration to follow up associations between exposures and metabolic disease outcomes to determine possible causality and mechanisms.
The Unit is also a part of Cambridge Population Health Sciences, a three department partnership of the Department of Public Health and Primary Care and the MRC Biostatistics Unit. Collectively, the Partnership pursues a wide range of research across epidemiology, biostatistics, population health and primary care, and delivers the Masters courses in Population Health Sciences.
The MRC Epidemiology Unit is studying the genetic, developmental, behavioural and environmental determinants of obesity, type 2 diabetes and related metabolic disorders, and contributing to the prevention of these disorders.
Corporate | Type | Tweets | Articles | |
---|---|---|---|---|
United Nations Office for Disarmament Affairs International development, International Affairs | United Nations Office for Disarmament Affairs International development, International Affairs | Other 19 May 2023 | | |
AstraZeneca Pharmaceutical, Pharmaceutical Manufacturing | AstraZeneca Pharmaceutical, Pharmaceutical Manufacturing | Other 3 Apr 2024 | | |
Pfizer Pharmaceutical, Pharmaceutical Manufacturing | Pfizer Pharmaceutical, Pharmaceutical Manufacturing | Other 30 Nov 2022 | | |
UK Research and Innovation Public business cluster, Government Administration | UK Research and Innovation Public business cluster, Government Administration | Other 2 Jun 2023 | |